Literature DB >> 19070883

SV40: Cell transformation and tumorigenesis.

James M Pipas1.   

Abstract

The story of SV40-induced tumorigenesis and cellular transformation is intimately entwined with the development of modern molecular biology. Because SV40 and other viruses have small genomes and are relatively easy to manipulate in the laboratory, they offered tractable systems for molecular analysis. Thus, many of the early efforts to understand how eukaryotes replicate their DNA, regulate expression of their genes, and translate mRNA were focused on viral systems. The discovery that SV40 induces tumors in certain laboratory animals and transforms many types of cultured cells offered the first opportunity to explore the molecular basis for cancer. The goal of this article is to highlight some of the experiments that have led to our current view of SV40-induced transformation and to provide some context as to how they contributed to basic research in molecular biology and to our understanding of cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19070883     DOI: 10.1016/j.virol.2008.11.024

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  53 in total

1.  Identification of African Elephant Polyomavirus in wild elephants and the creation of a vector expressing its viral tumor antigens to transform elephant primary cells.

Authors:  Virginia R Pearson; Jens B Bosse; Orkide O Koyuncu; Julian Scherer; Cristhian Toruno; Rosann Robinson; Lisa M Abegglen; Joshua D Schiffman; Lynn W Enquist; Glenn F Rall
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

2.  Effects of route of inoculation and viral genetic variation on antibody responses to polyomavirus SV40 in Syrian golden hamsters.

Authors:  Jody L Swain; Vojtech Sroller; Connie Wong; Shaojie Zhang; Steven J Halvorson; Alan J Herron; Claudia A Kozinetz; Janet S Butel
Journal:  Comp Med       Date:  2012-10       Impact factor: 0.982

3.  Removal of a small C-terminal region of JCV and SV40 large T antigens has differential effects on transformation.

Authors:  Nicole T M Seneca; Maria Teresa Sáenz Robles; James M Pipas
Journal:  Virology       Date:  2014-08-16       Impact factor: 3.616

4.  Simian virus 40 large T antigen induces IFN-stimulated genes through ATR kinase.

Authors:  Adriana Forero; Nicholas S Giacobbi; Kevin D McCormick; Ole V Gjoerup; Christopher J Bakkenist; James M Pipas; Saumendra N Sarkar
Journal:  J Immunol       Date:  2014-05-05       Impact factor: 5.422

Review 5.  Ubiquitination at the interface of tumor viruses and DNA damage responses.

Authors:  Joseph M Dybas; Christin Herrmann; Matthew D Weitzman
Journal:  Curr Opin Virol       Date:  2018-09-24       Impact factor: 7.090

6.  Polyomavirus T antigens activate an antiviral state.

Authors:  Nicholas S Giacobbi; Tushar Gupta; Andrew T Coxon; James M Pipas
Journal:  Virology       Date:  2015-01-10       Impact factor: 3.616

7.  Prospective Study of Human Polyomaviruses and Risk of Cutaneous Squamous Cell Carcinoma in the United States.

Authors:  Anala Gossai; Tim Waterboer; Heather H Nelson; Jennifer A Doherty; Angelika Michel; Martina Willhauck-Fleckenstein; Shohreh F Farzan; Brock C Christensen; Anne G Hoen; Ann E Perry; Michael Pawlita; Margaret R Karagas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02-11       Impact factor: 4.254

8.  Development and characterization of a stable bovine intestinal sub-epithelial myofibroblast cell line from ileum of a young calf.

Authors:  Tirth Uprety; Brionna B Spurlin; Linto Antony; Chithra Sreenivasan; Alan Young; Feng Li; Michael B Hildreth; Radhey S Kaushik
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-06-10       Impact factor: 2.416

9.  Merkel Cell Polyomavirus Infection of Animal Dermal Fibroblasts.

Authors:  Wei Liu; Nathan A Krump; Margo MacDonald; Jianxin You
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

Review 10.  Chronic viral infection and primary central nervous system malignancy.

Authors:  Robert Saddawi-Konefka; John R Crawford
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.